EUVIMEDEUVIMED entdecken
Crossref

Ramadan fasting and glycemic control in patients with type 2 diabetes: A real-world data analysis

Swan-Abu Salih A, G Chodick, P Klein, S Eilat-Adar

Primary Care Diabetes · 2025

DOI: 10.1016/j.pcd.2024.12.010 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Primary Care Diabetes, 2025. Verfasst von Swan-Abu Salih A und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology and Preventive Medicine, School of Public Health, Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Fasting, Islam, Blood Glucose. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 28 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: The aim of this study is to assess the impact of Ramadan intermittent fasting on glycemic control in individuals diagnosed with type 2 diabetes. METHODS: This historical prospective study utilized electronic health records from a major state-mandated healthcare provider. The research sample included Muslim adults aged 40-70 years, who had been diagnosed with type 2 diabetes. Their place of residence, categorized as a yes/no predominantly Muslim-Arab city, was identified for analysis purposes. Data regarding fasting plasma glucose and HbA1C levels were extracted from the 90 days preceding and the 45 days following the Ramadan period, spanning across six years (2011-2016). The annual data were aggregated and analyzed using a mixed-model ANOVA. RESULTS: Muslim participants during Ramadan were found to have a higher likelihood of experiencing a change in HbA1C levels of ≥ 0.5 % compared to their non-Muslim counterparts, displaying an odds ratio (OR) of 1.89 (95 % confidence interval [CI]: 1.24-2.88). Among Muslims with initially normal HbA1C levels (≤7 %), there was a heightened risk of both decreased (≤-0.5 %) HbA1C levels (OR=2.62, 95 % CI: 1.15-6.00) and increased (≥+0.5 %) HbA1C levels (OR=2.85, 95 % CI: 1.24-6.57) in comparison to the non-Muslim group. CONCLUSIONS: In Muslims with type 2 diabetes, fasting during the Ramadan increases the risk of their HbA1C-levels rising by more than 0.5 %. These results underscore the potentially dual impact of Ramadan intermittent fasting on glycemic control in individuals with type 2 diabetes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2FastingIslamBlood GlucoseGlycemic ControlHumansMiddle AgedFemaleMaleGlycated HemoglobinAgedAdultBiomarkersProspective StudiesTime FactorsRisk FactorsElectronic Health RecordsTreatment OutcomeHypoglycemic AgentsRisk Assessment

Stichwörter der Autor:innen

Fasting glucoseGlycated hemoglobinHbA1CIntermittent fastMuslimsRamadanType 2 diabetes

Substanzen

Glycated HemoglobinBlood GlucoseBiomarkershemoglobin A1c protein, humanHypoglycemic Agents

Autor:innen und Institutionen

  • Department of Epidemiology and Preventive Medicine, School of Public Health, Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel.
  • Division of Endocrinology, Diabetes and Metabolism, Sheba Medical Center, Ramat Gan, Israel; Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Macabi Health Services, Tel Aviv 6812509, Israel.
  • Department of Epidemiology and Preventive Medicine, School of Public Health, Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel; Levinsky-Wingate Academic College, Campus Wingate, Netanya 4290200, Israel…

Zitieren

APA

Salih A, S. A., Chodick, G., Klein, P., & Eilat-Adar, S. (2025). Ramadan fasting and glycemic control in patients with type 2 diabetes: A real-world data analysis. Primary Care Diabetes. https://doi.org/10.1016/j.pcd.2024.12.010

Vancouver

Salih A SA, Chodick G, Klein P, Eilat-Adar S. Ramadan fasting and glycemic control in patients with type 2 diabetes: A real-world data analysis. Primary Care Diabetes. 2025. doi:10.1016/j.pcd.2024.12.010

BibTeX
@article{SalihA2025,
  author = {Salih A, Swan-Abu and Chodick, G and Klein, P and Eilat-Adar, S},
  title = {Ramadan fasting and glycemic control in patients with type 2 diabetes: A real-world data analysis},
  journal = {Primary Care Diabetes},
  year = {2025},
  doi = {10.1016/j.pcd.2024.12.010}
}
Kostenlos starten →